MAX (Protein max) variants and mutations
MAX (also known as Protein max) is a human protein-coding gene encoding a protein. It forms DNA-binding dimers with MYC-family proteins and other partners, balancing transcriptional programs that promote or restrain proliferation. Germline loss-of-function variants predispose to pheochromocytoma and paraganglioma, while altered MAX-MYC signaling is central to many cancers. This analysis covers 671 MAX variants and mutations. Of these, 52% have computational variant effect predictions. Disease context includes pheochromocytoma, hereditary pheochromocytoma-paraganglioma, and polydactyly-macrocephaly syndrome. Example MAX variants include M1?, M1V, and S2G.
Variant analysis overview
- Gene: MAX
- Protein: Protein max
- UniProt accession: P61244
- Organism: Homo sapiens
- Variants analyzed: 671
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 538 unspecified-consequence records; 14 frameshift variants; 3 stop lost; 34 synonymous variants; 84 missense variants; 1 stop retained variant; 3 stop-gained variants; 1 in-frame deletions; 1 in-frame insertions
- Prediction scores: 352 variants have prediction scores (52% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: pheochromocytoma, hereditary pheochromocytoma-paraganglioma, polydactyly-macrocephaly syndrome, hereditary neoplastic syndrome, Inherited cancer-predisposing syndrome, plasma cell myeloma, neurodegenerative disease, endometrial cancer, colon adenocarcinoma, breast ductal adenocarcinoma, hepatobiliary neoplasm, nodular malignant melanoma.
Protein structure and variant hotspots
- Protein features: 1 domains; 10 post-translational modification sites.
- Structural context: 249 variants have structural context.
- PTM context: 20 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable MAX variants
Examples include M1?, M1V, S2G, S2R, D3E, D3G, D3N, D3V. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA Cosmic COSV5241, cosmic curated COSV52416, cosmic curated COSV10455, Variant assessed as somatic; high impact.
- M1V (p.Met1Val), rs387906649, ClinGen CA128636, ClinVar RCV000022652, ClinVar RCV000850061, MetaLR 0.98, MetaSVM 1.07, Uncertain significance, Hereditary pheochromocytoma and paraganglioma
- S2G (p.Ser2Gly), Ensembl rs2139977667
- S2R (p.Ser2Arg), ESP rs138539686, ExAC rs138539686, TOPMed rs138539686, gnomAD rs138539686, Likely benign
- D3E (p.Asp3Glu), Ensembl rs2139977548, Uncertain significance, Hereditary cancer-predisposing syndrome
- D3G (p.Asp3Gly), Ensembl rs2063875234
- D3N (p.Asp3Asn), Ensembl rs2139977597
- D3V (p.Asp3Val), NCI-TCGA Cosmic COSV5241, cosmic curated COSV52417, Variant assessed as somatic; moderate impact.
- N4T (p.Asn4Thr), Ensembl rs2139977495
- N4Y (p.Asn4Tyr), Ensembl rs2139977523
- D5E (p.Asp5Glu), Ensembl rs2139977386, REVEL 0.46, CADD 23.00, Uncertain significance, Hereditary cancer-predisposing syndrome
- D5G (p.Asp5Gly), rs150113270, ClinGen CA262729187, ClinVar RCV000572230, ClinVar RCV001858371, REVEL 0.78, CADD 32.00, Uncertain significance, Hereditary cancer-predisposing syndrome; not provided; Hereditary pheochromocyto
- D5N (p.Asp5Asn), NCI-TCGA Cosmic COSV5241, cosmic curated COSV52418, Ensembl rs2139977443, Variant assessed as somatic; moderate impact.
- D5Y (p.Asp5Tyr), Ensembl rs2139977443
- D6E (p.Asp6Glu), gnomAD rs2063874870, Likely benign
- D6G (p.Asp6Gly), Ensembl rs2139977288
- D6N (p.Asp6Asn), Ensembl rs2139977361
- D6V (p.Asp6Val), Ensembl rs2139977288
- D6Y (p.Asp6Tyr), NCI-TCGA Cosmic COSV5241, cosmic curated COSV52415, Variant assessed as somatic; moderate impact.
- I7M (p.Ile7Met), rs760248675, ClinGen CA7233038, NCI-TCGA Cosmic COSV5241, NCI-TCGA Cosmic COSV9940, REVEL 0.63, CADD 23.80, Uncertain significance, Hereditary cancer-predisposing syndrome; Hereditary pheochromocytoma and paragan
- I7V (p.Ile7Val), rs1370344419, gnomAD 14-65077389-T-C, CADD 18.10
- E8* (p.Glu8Ter), rs752477890, ClinGen CA7233037, cosmic curated COSV52417, ClinVar RCV001015116, AlphaMissense 0.94, MetaLR 0.93, Pathogenic
- E8D (p.Glu8Asp), Ensembl rs2139977078, Uncertain significance, Hereditary pheochromocytoma and paraganglioma
- E8K (p.Glu8Lys), cosmic curated COSV52415, ExAC rs752477890, gnomAD rs752477890, Pathogenic
- E8V (p.Glu8Val), Ensembl rs2139977134
- V9E (p.Val9Glu), Ensembl rs2139976968
- V9G (p.Val9Gly), Ensembl rs2139976968
- V9L (p.Val9Leu), rs201743423, ClinGen CA7233036, cosmic curated COSV10608, ClinVar RCV000351964, REVEL 0.79, CADD 22.90, Conflicting interpretations, Pheochromocytoma; Hereditary cancer-predisposing syndrome; not provided
- V9M (p.Val9Met), NCI-TCGA Cosmic COSV5241, cosmic curated COSV52419, ExAC rs201743423, TOPMed rs201743423, Uncertain significance, Hereditary cancer-predisposing syndrome
- V9V (p.Val9Val), gnomAD 14-65077405-A-C, CADD 18.40
- E10K (p.Glu10Lys), rs2139976890, ClinGen CA390038962, cosmic curated COSV52420, ClinVar RCV004513573, AlphaMissense 0.95, MetaLR 0.97, Uncertain significance, Hereditary cancer-predisposing syndrome
- S11C (p.Ser11Cys), Ensembl rs2139976798
- S11G (p.Ser11Gly), Ensembl rs2139976798
- S11R (p.Ser11Arg), Ensembl rs2139976747, Likely benign
- D12A (p.Asp12Ala), Ensembl rs2139976654
- D12E (p.Asp12Glu), rs370402660, ClinGen CA7233035, ClinVar RCV001020917, ClinVar RCV001323560, REVEL 0.59, CADD 26.10, Uncertain significance, Hereditary pheochromocytoma and paraganglioma; Hereditary cancer-predisposing sy
- D12N (p.Asp12Asn), rs2063874476, ClinGen CA390038931, ClinVar RCV002041672, Ensembl rs2063874476, AlphaMissense 0.61, MetaLR 0.98, Uncertain significance, Hereditary pheochromocytoma and paraganglioma
- D12V (p.Asp12Val), Ensembl rs2139976654
- D12Y (p.Asp12Tyr), rs2063874476, ClinGen CA390038928, ClinVar RCV001054748, ClinVar RCV004789388, REVEL 0.76, AlphaMissense 0.61, Uncertain significance, Pheochromocytoma; Hereditary pheochromocytoma and paraganglioma
- D12D (p.Asp12Asp), gnomAD 14-65077411-A-G, CADD 17.60
- E13* (p.Glu13Ter), Ensembl rs2139964646, CADD 50.00
- E13G (p.Glu13Gly), rs2504510560, ClinGen CA390038823, ClinVar RCV002829353, ClinVar RCV005592510, Uncertain significance, Hereditary pheochromocytoma and paraganglioma; Hereditary cancer-predisposing sy
- E13K (p.Glu13Lys), NCI-TCGA TCGA novel, Ensembl rs2139964646, REVEL 0.59, CADD 27.10, Variant assessed as somatic; moderate impact.
- E13Q (p.Glu13Gln), Ensembl rs2139964646
- E13R (p.Glu13Arg), rs2504510600, ClinGen CA2697553970, ClinVar RCV003518148, Pathogenic
- E14D (p.Glu14Asp), cosmic curated COSV52415, TOPMed rs1350578690, gnomAD rs1350578690, REVEL 0.24, CADD 20.60, Likely benign
- E14G (p.Glu14Gly), rs876660888, ClinGen CA10579868, ClinVar RCV000213097, ClinVar RCV000475591, REVEL 0.30, CADD 28.70, Uncertain significance, Hereditary cancer-predisposing syndrome; not provided; Hereditary pheochromocyto
- E14Q (p.Glu14Gln), ExAC rs754684431, gnomAD rs754684431, REVEL 0.32, CADD 23.30
- E14V (p.Glu14Val), TOPMed rs876660888, gnomAD rs876660888, Uncertain significance
- Q15* (p.Gln15Ter), Ensembl rs2139964405, CADD 40.00
- Q15E (p.Gln15Glu), Ensembl rs2139964405
- Q15H (p.Gln15His), Ensembl rs2139964326, Uncertain significance, Hereditary cancer-predisposing syndrome
- Q15R (p.Gln15Arg), cosmic curated COSV52414, Ensembl rs2139964381
- P16A (p.Pro16Ala), rs751344230, ClinGen CA390038769, ClinVar RCV002923363, ClinVar RCV003308346, REVEL 0.34, CADD 22.80, Uncertain significance, Hereditary cancer-predisposing syndrome; Hereditary pheochromocytoma and paragan
- P16L (p.Pro16Leu), rs2063834899, ClinGen CA390038765, ClinVar RCV001303088, ClinVar RCV002341602, REVEL 0.47, CADD 23.70, Uncertain significance, Pheochromocytoma; Hereditary cancer-predisposing syndrome; Hereditary pheochromo
- P16Q (p.Pro16Gln), Ensembl rs2063834899, REVEL 0.46, CADD 23.30, Uncertain significance
- P16R (p.Pro16Arg), Ensembl rs2063834899, Uncertain significance
- P16T (p.Pro16Thr), rs751344230, ClinGen CA7232996, ClinVar RCV003633160, ClinVar RCV005592769, REVEL 0.41, CADD 22.60, Uncertain significance, Hereditary cancer-predisposing syndrome; Hereditary pheochromocytoma and paragan
- P16H (p.Pro16His), rs747874757, gnomAD 14-65076611-G-T, CADD 9.31
- R17K (p.Arg17Lys), rs1309179207, ClinGen CA390038754, ClinVar RCV003879373, gnomAD rs1309179207, AlphaMissense 0.45, MetaLR 0.91, Uncertain significance, Hereditary pheochromocytoma and paraganglioma
- R17M (p.Arg17Met), gnomAD rs1309179207, REVEL 0.49, AlphaMissense 0.45, Uncertain significance
- R17S (p.Arg17Ser), Ensembl rs2063834526, Likely benign
- R17T (p.Arg17Thr), gnomAD rs1309179207, Uncertain significance, Hereditary pheochromocytoma and paraganglioma
- R17W (p.Arg17Trp), Ensembl rs2139964122
- R17Q (p.Arg17Gln), rs761220254, gnomAD 14-65076644-C-T, CADD 13.00
- R17* (p.Arg17Ter), rs769051095, gnomAD 14-65076645-G-A, REVEL 0.29, AlphaMissense 0.22
- F18I (p.Phe18Ile), rs2139963969, ClinGen CA390038746, ClinVar RCV002039569, ClinVar RCV002343888, AlphaMissense 0.92, MetaLR 0.94, Uncertain significance, Hereditary pheochromocytoma and paraganglioma; Hereditary cancer-predisposing sy
- F18L (p.Phe18Leu), gnomAD rs1328060222, Uncertain significance
- F18V (p.Phe18Val), Ensembl rs2139963969, Uncertain significance, Hereditary pheochromocytoma and paraganglioma
- F18Y (p.Phe18Tyr), Ensembl rs2139963944
- F18C (p.Phe18Cys), gnomAD 14-65077382-A-C, CADD 18.50
- Q19* (p.Gln19Ter), rs2139963878, ClinGen CA390038728, ClinVar RCV001389671, ClinVar RCV003136061, Pathogenic
- Q19H (p.Gln19His), rs1395966308, ClinGen CA390038723, ClinVar RCV001338646, ClinVar RCV002357178, REVEL 0.30, CADD 20.70, Uncertain significance, Hereditary cancer-predisposing syndrome; Hereditary pheochromocytoma and paragan
- Q19L (p.Gln19Leu), rs200547781, ClinGen CA7232993, ClinVar RCV000473057, ClinVar RCV000562291, REVEL 0.33, CADD 23.20, Conflicting interpretations, not specified; Hereditary pheochromocytoma and paraganglioma; Pheochromocytoma
- Q19R (p.Gln19Arg), ExAC rs200547781, TOPMed rs200547781, gnomAD rs200547781, REVEL 0.29, CADD 22.60, Benign
- S20C (p.Ser20Cys), TOPMed rs2063833795, Uncertain significance
- S20F (p.Ser20Phe), TOPMed rs2063833795, Uncertain significance, Hereditary cancer-predisposing syndrome; Hereditary pheochromocytoma and paragan
- S20P (p.Ser20Pro), rs2063833930, ClinGen CA390038716, ClinVar RCV001365564, ClinVar RCV006391965, AlphaMissense 0.26, MetaLR 0.93, Uncertain significance, Hereditary cancer-predisposing syndrome; Hereditary pheochromocytoma and paragan
- S20Y (p.Ser20Tyr), rs2063833795, ClinGen CA390038712, ClinVar RCV003635169, REVEL 0.30, CADD 26.60, Uncertain significance, Hereditary pheochromocytoma and paraganglioma
- S20A (p.Ser20Ala), rs1328075485, gnomAD 14-65077374-A-C, CADD 18.40
- S20S (p.Ser20Ser), gnomAD 14-65077378-A-G, CADD 18.70
- A21G (p.Ala21Gly), Ensembl rs2063833647
- A21P (p.Ala21Pro), Ensembl rs2139963646
- A21S (p.Ala21Ser), Ensembl rs2139963646
- A21T (p.Ala21Thr), Ensembl rs2139963646
- A21V (p.Ala21Val), Ensembl rs2063833647, REVEL 0.27, CADD 27.20
- A22D (p.Ala22Asp), gnomAD rs1420088914, REVEL 0.62, CADD 24.30
- A22G (p.Ala22Gly), gnomAD rs1420088914
- A22P (p.Ala22Pro), gnomAD rs1435018573, Uncertain significance
- A22S (p.Ala22Ser), gnomAD rs1435018573, REVEL 0.51, CADD 24.30, Uncertain significance, Hereditary cancer-predisposing syndrome; Hereditary pheochromocytoma and paragan
- A22T (p.Ala22Thr), gnomAD rs1435018573, REVEL 0.51, CADD 23.90, Uncertain significance, Hereditary pheochromocytoma and paraganglioma
- A22V (p.Ala22Val), gnomAD rs1420088914, REVEL 0.47, CADD 24.20, Uncertain significance, Hereditary pheochromocytoma and paraganglioma
- D23E (p.Asp23Glu), Ensembl rs2139887233, REVEL 0.43, CADD 21.40, Uncertain significance, in PCC
- D23H (p.Asp23His), cosmic curated COSV52415, Ensembl rs2139887316, Uncertain significance, in PCC
- D23N (p.Asp23Asn), rs2139887316, UniProt VAR 079348, Ensembl rs2139887316, REVEL 0.52, CADD 23.10, Uncertain significance, Hereditary pheochromocytoma and paraganglioma
- D23V (p.Asp23Val), rs2139887283, ClinGen CA390037829, ClinVar RCV002650142, Ensembl rs2139887283, AlphaMissense 0.89, MetaLR 0.96, Uncertain significance, Hereditary pheochromocytoma and paraganglioma
- K24* (p.Lys24Ter), NCI-TCGA TCGA novel, Ensembl rs2139887180, Variant assessed as somatic; high impact.
- K24I (p.Lys24Ile), TOPMed rs1174960252, Uncertain significance
- K24N (p.Lys24Asn), Ensembl rs2139887057
- K24R (p.Lys24Arg), rs1174960252, ClinGen CA390037821, ClinVar RCV001057621, ClinVar RCV003478683, REVEL 0.51, CADD 23.30, Uncertain significance, not provided; Hereditary pheochromocytoma and paraganglioma; Hereditary cancer-p
- K24T (p.Lys24Thr), TOPMed rs1174960252, Uncertain significance
- R25G (p.Arg25Gly), Ensembl rs2139886995, Likely pathogenic, in PCC
- R25Q (p.Arg25Gln), gnomAD rs1386979906, REVEL 0.89, CADD 27.70
- R25W (p.Arg25Trp), rs2139886995, cosmic curated COSV10800, UniProt VAR 079349, Ensembl rs2139886995, REVEL 0.95, CADD 32.00, Conflicting interpretations, Hereditary cancer-predisposing syndrome; Hereditary pheochromocytoma and paragan
- R25K (p.Arg25Lys), rs1595127306, gnomAD 14-65076623-C-T, AlphaMissense 0.20, MetaLR 0.37
- A26S (p.Ala26Ser), Ensembl rs2139886859
- A26T (p.Ala26Thr), cosmic curated COSV10954, Ensembl rs2139886859, REVEL 0.71, CADD 27.20
- A26V (p.Ala26Val), Ensembl rs2139886837
- H27D (p.His27Asp), Ensembl rs2139886754
- H27L (p.His27Leu), gnomAD rs1156807933
- H27P (p.His27Pro), gnomAD rs1156807933
- H27Q (p.His27Gln), Ensembl rs2139886632
- H27R (p.His27Arg), gnomAD rs1156807933, REVEL 0.77, CADD 24.20
- H27Y (p.His27Tyr), Ensembl rs2139886754
- H27H (p.His27His), gnomAD 14-65077384-G-A, CADD 17.90
- H28D (p.His28Asp), Ensembl rs2139886569
- H28L (p.His28Leu), Ensembl rs2139886525
- H28P (p.His28Pro), Ensembl rs2139886525
- H28Q (p.His28Gln), Ensembl rs2139886462, Likely benign
- H28R (p.His28Arg), NCI-TCGA Cosmic COSV5241, cosmic curated COSV52415, Ensembl rs2139886525, Variant assessed as somatic; moderate impact.
- H28Y (p.His28Tyr), Ensembl rs2139886569
- N29D (p.Asn29Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N29I (p.Asn29Ile), Ensembl rs2139886421
- N29K (p.Asn29Lys), ExAC rs771488967, gnomAD rs771488967, Likely benign
- N29T (p.Asn29Thr), Ensembl rs2139886421
- N29Y (p.Asn29Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N29S (p.Asn29Ser), rs772661746, gnomAD 14-65076629-T-C, AlphaMissense 0.10, MetaLR 0.11
- A30G (p.Ala30Gly), Ensembl rs2139886268
- A30P (p.Ala30Pro), cosmic curated COSV52416, Ensembl rs2139886318
- A30S (p.Ala30Ser), Ensembl rs2139886318
- A30T (p.Ala30Thr), Ensembl rs2139886318
- A30V (p.Ala30Val), Ensembl rs2139886268
- L31P (p.Leu31Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L31Q (p.Leu31Gln), Ensembl rs2139886111
- L31V (p.Leu31Val), Ensembl rs1595166940, Likely benign
- L31W (p.Leu31Trp), rs767291215, gnomAD 14-65077368-TGAGG, CADD 16.40
- L31L (p.Leu31Leu), rs368362953, gnomAD 14-65077369-G-T, CADD 17.50
- L31F (p.Leu31Phe), rs769142713, gnomAD 14-65077371-G-A, CADD 17.70
- E32* (p.Glu32Ter), cosmic curated COSV52419, Ensembl rs2139886012
- E32D (p.Glu32Asp), Ensembl rs2139885959, Likely benign
- E32K (p.Glu32Lys), NCI-TCGA Cosmic COSV5241, cosmic curated COSV52416, Variant assessed as somatic; moderate impact.
- E32Q (p.Glu32Gln), gnomAD 14-65077365-C-G, CADD 17.40
- R33* (p.Arg33Ter), rs387906651, NCI-TCGA Cosmic COSV5241, cosmic curated COSV52415, Ensembl rs387906651, AlphaMissense 1.00, MetaLR 0.99, Pathogenic
- R33G (p.Arg33Gly), Ensembl rs387906651, Pathogenic
- R33P (p.Arg33Pro), Ensembl rs2139885819, Uncertain significance
- R33Q (p.Arg33Gln), rs2139885819, ClinGen CA390037763, ClinVar RCV003633001, Ensembl rs2139885819, AlphaMissense 1.00, MetaLR 0.99, Uncertain significance, Hereditary pheochromocytoma and paraganglioma
- K34* (p.Lys34Ter), Ensembl rs2139885747
- K34I (p.Lys34Ile), Ensembl rs2139885701
- K34N (p.Lys34Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- K34Q (p.Lys34Gln), Ensembl rs2139885747
- K34R (p.Lys34Arg), Ensembl rs2139885701
- K34E (p.Lys34Glu), rs1459488775, gnomAD 14-65077353-T-C, CADD 22.30
- R35C (p.Arg35Cys), rs2139885633, NCI-TCGA Cosmic COSV5241, cosmic curated COSV52419, UniProt VAR 079351, REVEL 0.85, CADD 32.00, Pathogenic, in PCC
- R35H (p.Arg35His), rs2139885593, ClinGen CA390037749, NCI-TCGA Cosmic COSV5241, cosmic curated COSV52416, AlphaMissense 1.00, MetaLR 0.99, Uncertain significance, Hereditary pheochromocytoma and paraganglioma
- R35L (p.Arg35Leu), NCI-TCGA Cosmic COSV5241, cosmic curated COSV52416, Variant assessed as somatic; moderate impact., in PCC
- R35P (p.Arg35Pro), NCI-TCGA Cosmic COSV5241, cosmic curated COSV52418, Uncertain significance, in PCC
- R36G (p.Arg36Gly), NCI-TCGA Cosmic COSV5241, cosmic curated COSV52418, Ensembl rs2139885494, Variant assessed as somatic; moderate impact.
- R36K (p.Arg36Lys), NCI-TCGA TCGA novel, Ensembl rs2139885416, Variant assessed as somatic; moderate impact.
- R36M (p.Arg36Met), Ensembl rs2139885416
- R36S (p.Arg36Ser), NCI-TCGA TCGA novel, Ensembl rs2139885374, Likely benign
- R36T (p.Arg36Thr), Ensembl rs2139885416
- R36W (p.Arg36Trp), cosmic curated COSV10455, NCI-TCGA Cosmic COSV5241, Ensembl rs2139885494, Variant assessed as somatic; moderate impact.
- D37A (p.Asp37Ala), cosmic curated COSV10605, ExAC rs747617797, gnomAD rs747617797
- D37E (p.Asp37Glu), Ensembl rs2139885160
- D37G (p.Asp37Gly), cosmic curated COSV52420, ExAC rs747617797, gnomAD rs747617797
- D37H (p.Asp37His), Ensembl rs2139885305
- D37N (p.Asp37Asn), Ensembl rs2139885305, Uncertain significance, Hereditary pheochromocytoma and paraganglioma
- D37V (p.Asp37Val), ExAC rs747617797, gnomAD rs747617797
- D37Y (p.Asp37Tyr), Ensembl rs2139885305
- H38D (p.His38Asp), Ensembl rs2139885088
- H38N (p.His38Asn), Ensembl rs2139885088
- H38P (p.His38Pro), NCI-TCGA TCGA novel, Ensembl rs2139885037, Variant assessed as somatic; moderate impact.
- H38Q (p.His38Gln), Ensembl rs2139884980, REVEL 0.70, CADD 24.10, Likely benign
- H38Y (p.His38Tyr), Ensembl rs2139885088
- I39F (p.Ile39Phe), Ensembl rs2063580953, Uncertain significance
- I39L (p.Ile39Leu), Ensembl rs2063580953, Uncertain significance
- I39M (p.Ile39Met), Ensembl rs2139884766
- I39N (p.Ile39Asn), Ensembl rs2139884859
- I39T (p.Ile39Thr), Ensembl rs2139884859
- I39V (p.Ile39Val), Ensembl rs2063580953, Uncertain significance, Hereditary pheochromocytoma and paraganglioma
Public MAX analysis runs
- MAX analysis run — MAX (671 variants) — completed 2026-08-21